Amaranth Medical Initiates Clinical Trial of the Second-Generation FORTITUDE Bioresorbable Drug-Eluting Scaffold MOUNTAIN VIEW, CA, Sept. 16, 2014 (GLOBE NEWSWIRE) -- Amaranth Medical, a privately held medical device company, announced the initiation of patient enrollment in multiple centers in Colombia, South...

Coronary Stents - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2009-2015 Dublin, Oct. 23, 2013 (GLOBE NEWSWIRE) -- Dublin - Research and Markets (http://www.researchandmarkets.com/research/f9mkhm/coronary_stents) has announced the addition of the "Coronary...

Global Coronary Stents - Market Growth Analysis, 2009-2015 Dublin, Oct. 4, 2013 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/thlsqn/global_coronary) has announced the addition of the "Global Coronary Stents - Market...

Bypass Surgery More Cost Effective Than Stents for Diabetics Long Term Study Highlights: Bypass surgery is more cost effective than drug-covered stents for people with diabetes who have multiple clogged heart arteries. Initially, bypass surgery may cost more...

Bypass Surgery Significantly Better Than Stents for Treating Multiple Blockages in Diabetics Study Highlights: Patients with diabetes who have multiple clogged heart arteries fared significantly better when treated with bypass surgery than drug-covered stents. These patients were...